SGMO vs NSRX
Comparison between Sangamo Therapeutics Inc (SGMO, Company) and Nasus Pharma Ltd (NSRX, Company).
Both SGMO and NSRX are from the Healthcare sector.
SGMO vs NSRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
SGMO
$29M
Winner
NSRX
$29M
Max Drawdown
SGMO
99.85%
Winner
NSRX
78.03%
Sharpe Ratio
SGMO
-0.77
Winner
NSRX
-0.48
5Y Beta
SGMO
N/A
NSRX
0.69
Industry
SGMO
Biotechnology
NSRX
Drug Manufacturers - General
P/E Ratio
SGMO
-0.23
Winner
NSRX
-4.94
Forward P/E
SGMO
0.40
NSRX
N/A
PEG Ratio
SGMO
N/A
NSRX
-0.02
5Y EPS CAGR
SGMO
-3.12%
NSRX
N/A
Debt to Equity
SGMO
0.00%
NSRX
0.00%
Free Cash Flow Yield
SGMO
N/A
NSRX
-17.04%
SGMO vs NSRX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
SGMO
+0.00%
NSRX
-9.14%
3M
SGMO
-37.92%
Winner
NSRX
+17.78%
6M
SGMO
-86.18%
Winner
NSRX
-44.60%
1Y
SGMO
-86.42%
Winner
NSRX
-61.45%
5Y(CAGR)
SGMO
-62.20%
NSRX
N/A
10Y(CAGR)
SGMO
-35.91%
NSRX
N/A
Max(CAGR)
Winner
SGMO
-18.29%
NSRX
-62.92%
SGMO vs NSRX - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | SGMO | NSRX |
|---|---|---|
| 2026 | -83.13% | -57.88% |
| 2025 | -62.83% | +10.91% |
| 2024 | +83.35% | N/A |
| 2023 | -82.70% | N/A |
| 2022 | -59.85% | N/A |
| 2021 | -52.89% | N/A |
| 2020 | +90.07% | N/A |
| 2019 | -28.95% | N/A |
| 2018 | -34.59% | N/A |
| 2017 | +429.03% | N/A |
| 2016 | -65.92% | N/A |
| 2015 | -40.21% | N/A |
| 2014 | +10.30% | N/A |
| 2013 | +125.85% | N/A |
| 2012 | +103.04% | N/A |
| 2011 | -59.72% | N/A |
| 2010 | +8.14% | N/A |
| 2009 | +61.31% | N/A |
| 2008 | -72.25% | N/A |
| 2007 | +97.29% | N/A |
| 2006 | +60.98% | N/A |
| 2005 | -30.52% | N/A |
| 2004 | +9.29% | N/A |
| 2003 | +59.48% | N/A |
| 2002 | -66.14% | N/A |
| 2001 | -45.86% | N/A |
| 2000 | +29.48% | N/A |
SGMO vs NSRX Drawdown Comparison
The maximum drawdown for SGMO was -99.85%, occurring on Jun 23, 2026. This drawdown has not yet recovered.
The maximum drawdown for NSRX was -78.03%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current SGMO drawdown is -99.85%. The current NSRX drawdown is -65.25%.
| Rank | SGMO | NSRX |
|---|---|---|
| #1 | -99.85% Sep 1, 2000 - Jun 23, 2026 | -78.03% Dec 31, 2025 - Mar 30, 2026 |
| #2 | -56.01% Apr 6, 2000 - Jun 12, 2000 | -30.96% Aug 19, 2025 - Dec 31, 2025 |
| #3 | -41.46% Jul 24, 2000 - Aug 29, 2000 | -2.42% Aug 13, 2025 - Aug 18, 2025 |
| #4 | -20.03% Jun 12, 2000 - Jun 20, 2000 | N/A |
| #5 | -15.18% Jul 11, 2000 - Jul 18, 2000 | N/A |
| #6 | -6.25% Jun 23, 2000 - Jun 27, 2000 | N/A |
| #7 | -5.08% Jul 5, 2000 - Jul 7, 2000 | N/A |
| #8 | -2.71% Jun 30, 2000 - Jul 5, 2000 | N/A |
| #9 | -0.54% Jun 28, 2000 - Jun 30, 2000 | N/A |
Correlation
Correlation between SGMO and NSRX is 0.78 which considered as a strong positive correlation - the stocks tend to move together.
0.78
-101
Select Stocks to Compare
Popular: SGMO vs SPYNSRX vs SPY
More Comparisons
Compare with similar stocks